Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Novelgene Technologies is an active biotechnology and scientific service provider specializing in genomics, proteomics, metabolomics, genetic testing/screening, and clinical research support. It serves clients in life sciences, hospital care, academic institutes, seed industry, and pharmaceutical companies with advanced laboratory capabilities. The firm has over 14 years of experience (team expertise) but was incorporated as a private limited entity in 2021. It does not have its own therapeutic pipeline or clinical results.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Novelgene Technologies.